title: Splenic radiation for corticosteroid-resistant immune thrombocytopenia.
abstract: OBJECTIVE
  To determine the role of splenic radiation as a treatment for immune thrombocytopenia.
  
  
  METHODS
  Retrospective analysis of an open, nonrandomized investigation.
  
  
  METHODS
  A regional cancer center, referred care, and primary care settings.
  
  
  METHODS
  Eleven older patients with idiopathic thrombocytopenic purpura (ITP) and 8 patients with secondary immune thrombocytopenia refractory to corticosteroid treatment for whom surgery would have posed a high risk.
  
  
  METHODS
  A short course (1 to 6 weeks) of radiation therapy to the spleen (total dose, 75 to 1370 cGy) with or without concurrent and postradiation corticosteroid administration.
  
  
  METHODS
  Efficacy was assessed by measuring any increase in the platelet count and by monitoring the duration of response and side effects.
  
  
  RESULTS
  Of 11 patients with ITP, 8 patients responded. Three patients had a sustained (greater than 52 weeks) increase in the platelet count to safe levels after therapy was discontinued. An additional patient had a sustained response but required intermittent, low-dose corticosteroids. Four other patients had increases in their platelet counts that lasted from 8 to 25 weeks. Two of the eight patients without ITP had a positive response, whereas four did not respond, and two were not evaluable. Patients had no adverse reactions to the radiation treatment.
  
  
  CONCLUSIONS
  Splenic radiation can be a safe and effective method to raise the platelet count in older patients with ITP that is refractory to corticosteroids and in whom the risks associated with splenectomy are high.
authors.affiliation: Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario, Canada.
authors.forename: D C
authors.initials: DC
authors.lastname: Calverley
authors.forename: G W
authors.initials: GW
authors.lastname: Jones
authors.forename: J G
authors.initials: JG
authors.lastname: Kelton
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D004351:Drug Resistance; D005260:Female; D006801:Humans; D015182:Lymphatic Irradiation; D008297:Male; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D013154:Spleen / Q000528:radiation effects*; D013921:Thrombocytopenia / Q000276:immunology / Q000532:radiotherapy*
chemical_list: D000305:Adrenal Cortex Hormones